Eudaimonia Partners’s Lydall, Inc. LDL Stock Holding History

Eudaimonia Partners’s Portfolio LDL Stock Details LDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-200	Closed	-$7K	–	1515
2021 Q1	$7K	Buy	+200	New	+$6.84K	﹤0.01%	1271

Other funds holding LDL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

JIC

Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Eudaimonia Partners's LDL Position: Q2 2021 in Review

Eudaimonia Partners sold out of Lydall, Inc. (LDL) in Q2 2021, closing a stake of 200 shares — an estimated $7K sold.

Eudaimonia Partners first reported a position in LDL in Q1 2021 and held it in 1 quarter. The position peaked at $7K in Q1 2021. 157 funds tracked by Wall St. Rank hold LDL as of Q2 2021.

Eudaimonia Partners reported no remaining Lydall, Inc. position as of Q2 2021 after selling out during the quarter.
Eudaimonia Partners sold 200 Lydall, Inc. shares in Q2 2021, an estimated $7K.
Eudaimonia Partners first reported a position in Lydall, Inc. in Q1 2021 and held it in 1 quarter.
Eudaimonia Partners's Lydall, Inc. position peaked at $7K in Q1 2021.
157 funds tracked by Wall St. Rank held Lydall, Inc. as of Q2 2021.

Based on Eudaimonia Partners's 13F filing for Q2 2021, filed 13 Aug 2021.